Gregg Named Vasogen CEO

Terrance Gregg, a special venture partner with Galen Associates, has been named president and CEO of Vasogen Inc. (Nasdaq: VSGN), an Ontario-based biotech company focused on the research and commercial development of technologies targeting the chronic inflammation underlying cardiovascular and neurological disease. www.vasogen.com< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />